Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Iran Presents New Anti-Cancer Nanodrug to Market

Abstract:
Iran presented to the market on Wednesday a new home-made nanodrug for chemotherapy, giving cancer patients a new hope.

Iran Presents New Anti-Cancer Nanodrug to Market

Tehran, Iran | Posted on June 16th, 2012

"The first home-made chemotherapy drug produced by utilizing nanotechnology was presented to the drug market today and can be used by gastrointestinal cancer patients," Iranian Deputy Health Minister for Food and Drugs Affairs Ebrahim Sheibani told reporters on Wednesday.

He said that after the domestic production of the nanodrug, Iran's imports of chemotherapy medicines have decreased by $5mln.

Noting that Iran is now producing 97% of its drug needs, Sheibani said that despite the western sanctions against Tehran, the country is not faced with any crisis in providing chemotherapy medicine for the patients.

Iran has made huge achievements in various fields of science and technology, from nuclear knowledge to stem cell and Nano technology.

In a most recent case, Iranian Health Minister Marziyeh Vahid Dastjerdi announced in September that the country would soon start production of 15 types of anti-cancer drugs.

"15 types of monoclonal anti-body drugs are being synthesized with the help of the Scientific Department of the Presidential Office, using hi-tech technology," Vahid Dastjerdi said.

Also earlier this year, Iranian scientists succeeded in producing new types of medication for treating different kinds of cancer, viral diseases and arthritis with 100% positive results.

Sheibani had also earlier this year announced that the Iranian scientists managed to break Israel's monopoly by producing a new MS drug which makes Iranian patients needless of foreign medicines.

"Fortunately, the production monopoly on the drug was broken by Iran's pharmaceutical industries and is now being distributed in our country's drug market," he told reporters in March.

He also reiterated that the drug can be used even during pregnancy by ready-made injection syringe technology.

Also, Iran shattered the United States' monopoly in the production of the most important drugs in the treatment of MS in 2007.

Interferon beta 1, generically known as Ziferon, is mainly injected subcutaneously and has antiviral and immunomodulating properties. The drug is mainly used in the management of multiple sclerosis, although its mode of action is unclear.

####

For more information, please click here

Copyright © Fars News Agency

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Leti to Demo Wristband with Embedded Sensors to Diagnose Sleep Apnea: APNEAband, Which Will Be Demonstrated at CES 2018, Also Monitors Mountain Sickness, Dehydration, Dialysis Treatment Response and Epileptic Seizures December 12th, 2017

Leti Develops World’s First Micro-Coolers for CERN Particle Detectors: Leti Design, Fabrication and Packaging Expertise Extends to Very Large Scientific Instruments December 11th, 2017

Untangling DNA: Researchers filter the entropy out of nanopore measurements December 8th, 2017

Device makes power conversion more efficient: New design could dramatically cut energy waste in electric vehicles, data centers, and the power grid December 8th, 2017

Nanomedicine

Leti to Demo Wristband with Embedded Sensors to Diagnose Sleep Apnea: APNEAband, Which Will Be Demonstrated at CES 2018, Also Monitors Mountain Sickness, Dehydration, Dialysis Treatment Response and Epileptic Seizures December 12th, 2017

Untangling DNA: Researchers filter the entropy out of nanopore measurements December 8th, 2017

Arrowhead Presents New Clinical Data Demonstrating a Sustained Host Response in Hepatitis B Patients Following RNAi Therapy — Up to 5.0 log10 reduction in HBsAg observed; data presented at HEP DART 2017 — December 6th, 2017

Copper will replace toxic palladium and expensive platinum in the synthesis of medications: The effectiveness of copper nanoparticles as a catalyst has been proven December 5th, 2017

Discoveries

UCLA chemists synthesize narrow ribbons of graphene using only light and heat: Tiny structures could be next-generation solution for smaller electronic devices December 8th, 2017

Untangling DNA: Researchers filter the entropy out of nanopore measurements December 8th, 2017

Device makes power conversion more efficient: New design could dramatically cut energy waste in electric vehicles, data centers, and the power grid December 8th, 2017

Wheat gets boost from purified nanotubes: Rice University toxicity study shows plant growth enhanced by -- but only by -- purified nanotubes December 6th, 2017

Announcements

Leti to Demo Wristband with Embedded Sensors to Diagnose Sleep Apnea: APNEAband, Which Will Be Demonstrated at CES 2018, Also Monitors Mountain Sickness, Dehydration, Dialysis Treatment Response and Epileptic Seizures December 12th, 2017

Leti Develops World’s First Micro-Coolers for CERN Particle Detectors: Leti Design, Fabrication and Packaging Expertise Extends to Very Large Scientific Instruments December 11th, 2017

Untangling DNA: Researchers filter the entropy out of nanopore measurements December 8th, 2017

Device makes power conversion more efficient: New design could dramatically cut energy waste in electric vehicles, data centers, and the power grid December 8th, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project